EI
CRMD icon

Ellevest Inc’s CorMedix CRMD Stock Holding History

Ellevest Inc’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-37
Closed – – 1652
2022
Q2 		$0 Buy
+37
New +$137 ﹤0.01% 1437

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ellevest Inc's CRMD Position: Q3 2022 in Review

Ellevest Inc sold out of CorMedix (CRMD) in Q3 2022, closing a stake of 37 shares.

Ellevest Inc first reported a position in CRMD in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 73 funds tracked by Wall St. Rank hold CRMD as of Q3 2022.

  • Ellevest Inc reported no remaining CorMedix position as of Q3 2022 after selling out during the quarter.
  • Ellevest Inc sold 37 CorMedix shares in Q3 2022.
  • Ellevest Inc first reported a position in CorMedix in Q2 2022 and held it in 1 quarter.
  • Ellevest Inc's CorMedix position peaked at $0 in Q2 2022.
  • 73 funds tracked by Wall St. Rank held CorMedix as of Q3 2022.

Based on Ellevest Inc's 13F filing for Q3 2022, filed 2 Nov 2022.